Overview

Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to help us better understand how metabolism responds to a low-carb diet when combined with an SGLT2 inhibitor.
Phase:
Phase 1
Details
Lead Sponsor:
AdventHealth Translational Research Institute
Treatments:
Sodium-Glucose Transporter 2 Inhibitors